In our current study, detecting the expression and methylation level of EDN3 both in clinical samples and cervical cancer cell lines, we confirmed the expression of EDN3 was decreased, but the methylation level of EDN3 was increased, with the degree of cervical lesions. The gene discussed is EDN3; the disease is cervical carcinoma.